Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to ‘Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R’ published in Vol. 24(3–4), pp. 311–316

"Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to ‘Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R’ published in Vol. 24(3–4), pp. 311–316." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ahead-of-print(ahead-of-print), pp. 1–2This article is related to:Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-RView responses to this article:The importance of understanding minimal important difference for ALSFRS-R: A reply to ‘Do we really need to calculate a minimal important difference for ALSFRS-R?’ https://doi.org/10.1080/21678421.2023.2248199 Conflicts of interest and competing interestsDr Vázquez- Costa is funded by grants of the Instituto de Salud Carlos III (JR19/00030, PI Vázquez) and received personal fees from Biogen and Roche outside the submitted work.